IRCTC stock doubles on listing day-Governor Koshyari asks people to use Khadi to empower rural artisans, Khadi Fashion Show at World Trade Centre-Google Arts and Culture unveiled its latest exhibit, "Crafted in India" in New Delhi amidst members of 21 partner institutions-MEDSCAPEINDIA 8TH AWARDS NIGHT MUMBAI-ON WORLD MENTAL HEALTH DAY, MUSIC FOR MENTAL HEALTH-NORTH BOMBAY SARBOJANIN DURGA PUJA SAMITIS MAHA ASHTAMI PUJA-DADASAHEB PHALKE AND PADMA VIBHUSHAN AWARDEE BOLLYWOOD STAR ICON ASHA BHOSLE AWARDED HONORARY DOCTORATE AS UNIVERSITY OF SALFORD STRENGTHENS INVESTMENT IN INDIA-Japan’s Nippon Life Insurance, announces the integration of Nippon India Mutual Fund (erstwhile Reliance Mutual Fund)-BALKRISHNA INDUSTRIES LIMITED (BKT) SCORES GLOBAL AGREEMENT WITH SPANISH FOOTBALL LEAGUE LALIGA-India’s premier Islamic travel show for Hajj, Umrah, Ziyarat and Halal travel operators and travel agents across India "Islamic Travel Mart" returns for its second edition at WTC, Mumbai-Mindfulness India Summit to be held on 30th & 31stof October, 2019 in Mumbai-Aishwarya Rai Bachchan at the trailer launch of Disney's upcoming film Maleficent- Mistress of Evil, in which she did hindi voice over of Actress Angelina Jolie-Aveny bags Emerging Warehousing Company of the Year Award-Ultra Media & Entertainment Group participates in Mipcom 2019 with Internationally acclaimed Indian titles & State of the Art Film Preservation and New Post Production Studio services-Sarwa Insurance, Egypt's leading finance solutions major selects 3i Infotech's PREMIA Astra-Himalaya Expands Its Hair Care Portfolio with Natural Shine Henna-11.09 million vacant houses in India; high potential for institutional rental housing: Knight Frank India and Khaitan& Co Report-Versatile talented Actress Jannat Zubair records mellifluous title track for Digital Reality Show Tokers house -Filmmaker Shadab Siddiqui Doesn't Regret For Not Having A Godfather In The Industry

Aditya Birla Sun Life Mutual Fund launches Aditya Birla Sun Life Pharma & Healthcare Fund

Screenshot_20190619_172702•An Open Ended equity scheme investing in Pharma and Healthcare Services Sector

 Key Highlights :

 ·       NFO opens on June 20, 2019and closes on July 4, 2019

·       Fund will invest in companies belonging to Indian Pharma, Hospitals, Diagnostics, Wellness & Speciality Chemicals, Contract Research and Manufacturing Services

·       Minimum application amount is Rs. 1000/- for the scheme

Mumbai, June 19, 2019 (GPN) : Aditya Birla Sun Life Mutual Fund, the mutual fund arm of Aditya Birla Capital Limited, has launched the Aditya Birla Sun Life Pharma & Healthcare Fund, an open ended equity scheme investing in Pharma and Healthcare Services Sector.The fund opens on June 20, 2019.

The Indian Pharma Industry is projected to become US$100bn industry by 2030, with domestic pharma expected to grow at 10-12% per annum. Indian Pharma companies are global leaders in generic drug manufacturing, in fact 1 in every 3 medications sold in the US is supplied by an Indian Pharma Company. The gradual global shift from branded to generic drugs will act as a tailwind and further fuel the exports market for Indian Pharma. Increased Government spending on public healthcare through schemes like ‘Ayushman Bharat’, growing penetration of health insurance, higher life expectancy and increasing spends towards healthcare and wellness will act as a stimulus for growth.

Commenting on the launch, A. Balasubramanian, CEO, Aditya Birla Sun Life AMC Ltd, said “The sector has been a long term outperformer over a 10 year period, except in the past 2-3 year. Poised for a strong rebound, there is opportunity in the coming market cycle to invest, given the attractive valuations and the potential growth in the sector”.

With a new business cycle coming into play and new businesses with high growth potential and sticky profit like Diagnostics, Wellness & Specialty Chemicals also available to invest in, this sector is more vibrant than ever before. “To add to novelty, we also have ability to invest in innovators, patent holders & specialty instrument makers in global markets”, added A Balasubramanian. Apart from the core Pharma and Healthcare space, the fund will also look at other large opportunities in sectors like Hospitals and Diagnostics growing at over 20% CAGR; Wellness businesses growing at 10-12% every year, or the Global Contract Research and Manufacturing Services industry (CRAMS) which is growing at 7% per annum. The scheme can also invest in equities of listed overseas companies, in line with the RBI and SEBI guidelines. The fund will be managed by Mr. Dhaval Shah. The benchmark index for the fund is S&P BSE Healthcare TRI (Total Return Index).

Data Source: IBEF, Internal Estimate, Evaluate Pharma, pmjay.gov.in, UN World Population Prospects, Mckinsey Global Institute report, National Health Profile 2015, 2018, IRDA Statistical Handbook 2016-17, Edelweiss Research

About the Author

Sachin Murdeshwar
Sachin Murdeshwar is a Sr.Journalist and Columnist in several Mainline Newspapers and Portals.He is an ardent traveller and likes to explore destinations to the core.